Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 7111 | Pharmaceutical Research | 6.8 | Q1 | Springer Nature | 79.0% 57/275 Pharmacology (medical) | 5066 | 749 |
| 7112 | Pulmonary Pharmacology and Therapeutics | 6.6 | Q1 | Elsevier | 79.0% 33/159 Pulmonary and Respiratory Medicine | 1137 | 173 |
| 7113 | Therapeutic Innovation and Regulatory Science | 3.8 | Q1 | Springer Nature | 79.0% 10/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 1666 | 433 |
| 7114 | HIV Medicine | 5.3 | Q1 | John Wiley & Sons | 78.0% 68/320 Health Policy | 2583 | 484 |
| 7115 | Chinese Journal of Integrative Medicine | 4.9 | Q1 | Chinese Journal of Integrated Traditional and Western Medicine Press | 78.0% 25/112 Complementary and Alternative Medicine | 2492 | 511 |
| 7116 | Expert Review of Neurotherapeutics | 6.4 | Q1 | Taylor & Francis | 77.0% 91/400 Neurology (clinical) | 2369 | 369 |
| 7117 | Journal of Dietary Supplements | 6.3 | Q1 | Taylor & Francis | 76.0% 66/275 Pharmacology (medical) | 1194 | 189 |
| 7118 | International Journal of Antimicrobial Agents | 5.8 | Q2 | Elsevier | 74.0% 72/275 Pharmacology (medical) | 5941 | 1018 |
| 7119 | Pharmacotherapy | 5.9 | Q2 | American College of Clinical Pharmacy | 74.0% 71/275 Pharmacology (medical) | 2189 | 368 |
| 7120 | Drugs and Aging | 6 | Q2 | Springer Nature | 74.0% 70/275 Pharmacology (medical) | 1960 | 324 |
| 7121 | Iranian Journal of Pharmaceutical Research | 3.9 | Q2 | Brieflands | 74.0% 20/77 General Pharmacology, Toxicology and Pharmaceutics | 1528 | 396 |
| 7122 | Annals of Pharmacotherapy | 5.8 | Q2 | SAGE | 73.0% 73/275 Pharmacology (medical) | 3164 | 543 |
| 7123 | International Journal of Pharmacy Practice | 2.8 | Q2 | Oxford University Press | 73.0% 13/47 Pharmacy | 857 | 311 |
| 7124 | American Journal of Cardiovascular Drugs | 5.4 | Q2 | Springer Nature | 73.0% 107/397 Cardiology and Cardiovascular Medicine | 1249 | 233 |
| 7125 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | Q2 | Bentham Science Publishers | 72.0% 77/275 Pharmacology (medical) | 823 | 146 |
| 7126 | Cancer Chemotherapy and Pharmacology | 5.7 | Q2 | Springer Nature | 72.0% 76/275 Pharmacology (medical) | 2889 | 508 |
| 7127 | Pharmaceutical Statistics | 3.2 | Q2 | John Wiley & Sons | 71.0% 85/293 Statistics and Probability | 1045 | 330 |
| 7128 | Drug Metabolism and Pharmacokinetics | 5.6 | Q2 | Japanese Society for the Study of Xenobiotics | 71.0% 79/275 Pharmacology (medical) | 1014 | 182 |
| 7129 | Clinical Therapeutics | 5.6 | Q2 | Elsevier | 71.0% 78/275 Pharmacology (medical) | 3560 | 638 |
| 7130 | Journal of Addiction Medicine | 5.4 | Q2 | Wolters Kluwer Health | 71.0% 166/580 Psychiatry and Mental Health | 3241 | 598 |
| 7131 | European Journal of Clinical Pharmacology | 5.5 | Q2 | Springer Nature | 70.0% 81/275 Pharmacology (medical) | 3699 | 673 |
| 7132 | Current Reviews in Clinical and Experimental Pharmacology | 3.5 | Q2 | Bentham Science Publishers | 70.0% 23/77 General Pharmacology, Toxicology and Pharmaceutics | 359 | 102 |
| 7133 | Pharmaceutical Medicine | 5.5 | Q2 | Springer Nature | 69.0% 84/275 Pharmacology (medical) | 714 | 131 |
| 7134 | JACCP Journal of the American College of Clinical Pharmacy | 2.6 | Q2 | John Wiley & Sons | 69.0% 15/47 Pharmacy | 1378 | 522 |
| 7135 | Clinical Drug Investigation | 5.4 | Q2 | Springer Nature | 68.0% 86/275 Pharmacology (medical) | 1874 | 347 |
| 7136 | Journal of Child and Adolescent Psychopharmacology | 3.5 | Q2 | Mary Ann Liebert | 68.0% 109/342 Pediatrics, Perinatology and Child Health | 806 | 233 |
| 7137 | Experimental and Clinical Psychopharmacology | 5 | Q2 | American Psychological Association | 67.0% 190/580 Psychiatry and Mental Health | 1838 | 369 |
| 7138 | Fundamental and Clinical Pharmacology | 5.3 | Q2 | John Wiley & Sons | 66.0% 94/275 Pharmacology (medical) | 2050 | 390 |
| 7139 | Journal of Acquired Immune Deficiency Syndromes (1999) | 5.3 | Q2 | Wolters Kluwer Health | 66.0% 93/275 Pharmacology (medical) | 4936 | 933 |
| 7140 | Expert Opinion on Drug Safety | 5.1 | Q2 | Taylor & Francis | 65.0% 96/275 Pharmacology (medical) | 2723 | 532 |